Expert synthesis of the 2023 NEJM retatrutide Phase II trial (LY3437943) for Da Nang (Danang) expat researchers. 24.2% weight reduction, cardiometabolic outcomes, safety profile, and implications for Danang metabolic research community.
2022–2024 tirzepatide research synthesized for Da Nang (Danang) expat researchers. SURMOUNT-1, SURMOUNT-4, SURPASS-CVOT, GIP receptor biology updates, and NASH liver fat data — with practical implications for the Danang expat community.
An expert-level analysis of the complete SURMOUNT clinical programme for tirzepatide (Tirz) — covering SURMOUNT-MMO 38% cardiovascular event reduction, SURMOUNT-OSA sleep apnoea FDA approval, SURMOUNT-3 lifestyle combination data, SURMOUNT-4 weight maintenance, body composition sub-studies, and the GIP paradox mechanism update. Essential reading for expert researchers in Hanoi / Ha Noi.
An expert-level research update on retatrutide (Reta) — covering the full Phase 2 dose-response analysis, the type 2 diabetes companion trial, NAFLD/NASH liver fat subgroup data, cardiac biomarker safety findings, the glucagon threshold mechanism, and Phase 3 TRIUMPH programme implications for researchers in Hanoi / Ha Noi.
An expert-level research update on BPC-157 + TB-500 covering the latest pre-clinical findings: neurological recovery and BBB penetration, gut-brain axis serotonin modulation, TB-500 cardiac cytoprotection from SERAPH trials, Ac-SDKP anti-fibrotic mechanisms, and in vitro synergy evidence for the Wolverine Stack — with implications for Hanoi / Ha Noi researchers.
A 2018–2024 research update on tesamorelin (tesa): new findings on NAFLD liver fat reduction, cognitive function improvement, cardiovascular markers, and emerging research in non-HIV populations — with relevance for the Hanoi / Ha Noi expat research community.
New tesamorelin (Tesa) research extends far beyond visceral fat: Stanley et al. (JCEM 2021) demonstrated significant NAFLD liver fat reduction; Fourman et al. (2019) showed cognitive function improvements; and growing longevity research connects GH/IGF-1 restoration to healthy aging. A research update for expats in Ho Chi Minh City and Saigon.
New research on BPC-157 and TB-500 (the Wolverine recovery stack) expands far beyond sports injury: neuroprotection in TBI models, TB-500 cardiac progenitor mobilization, gut-brain axis modulation, and multi-organ cytoprotection. This research update covers the latest evidence for expats in Ho Chi Minh City (Saigon).
The 2025–2026 tirzepatide (Tirz) research program expanded dramatically: SURMOUNT-5 showed 47% greater relative weight reduction vs. semaglutide 2.4mg; SURMOUNT-OSA demonstrated 63% sleep apnea reduction; SYNERGY-NASH showed MASH resolution; and neurodegeneration trials began. Full update for Ho Chi Minh City and Saigon expats.
Research review of retatrutide’s unique hepatic fat-targeting mechanism via glucagon receptor activation, Phase 2 liver enzyme and MRI-PDFF data, the TRIUMPH-MASH Phase 3 trial, and why NASH is especially relevant for expats in Ho Chi Minh City and Saigon.
